Drugs / Swine A/H1N1 influenza vaccine (split virion, inactivated)
Swine A/H1N1 influenza vaccine (split virion, inactivated)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00954798 | Aug 2009 → Dec 2010 | swine influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Swine A/H1N1 influenza vaccine (split virion, inactivated) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00954798 ↗ |
| Modality | Vaccine | “Immunogenicity and Safety of Multiple Formulations of an Intramuscular Inactivated, Split Virion Swine-origin A/H1N1 Influenza Vaccine” NCT00954798 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular on Day 0 and day 21 (all participants)” NCT00954798 ↗ |